163 related articles for article (PubMed ID: 36423787)
1. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents.
Hashemi M; Mirdamadi MSA; Talebi Y; Khaniabad N; Banaei G; Daneii P; Gholami S; Ghorbani A; Tavakolpournegari A; Farsani ZM; Zarrabi A; Nabavi N; Zandieh MA; Rashidi M; Taheriazam A; Entezari M; Khan H
Pharmacol Res; 2023 Jan; 187():106568. PubMed ID: 36423787
[TBL] [Abstract][Full Text] [Related]
2. Biological and therapeutic viewpoints towards role of miR-218 in human cancers: Revisiting molecular interactions and future clinical translations.
Hashemi M; Gholami S; Raesi R; Sarhangi S; Mahmoodieh B; Koohpar ZK; Goharrizi MASB; Behroozaghdam M; Entezari M; Salimimoghadam S; Zha W; Rashidi M; Abdi S; Taheriazam A; Nabavi N
Cell Signal; 2023 Sep; 109():110786. PubMed ID: 37380085
[TBL] [Abstract][Full Text] [Related]
3. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
Liu J; Chen M; Ma L; Dang X; Du G
Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
5. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
6. The dual role of microRNA (miR)-20b in cancers: Friend or foe?
İlhan A; Golestani S; Shafagh SG; Asadi F; Daneshdoust D; Al-Naqeeb BZT; Nemati MM; Khalatbari F; Yaseri AF
Cell Commun Signal; 2023 Jan; 21(1):26. PubMed ID: 36717861
[TBL] [Abstract][Full Text] [Related]
7. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
[TBL] [Abstract][Full Text] [Related]
8. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
Shan G; Zhou X; Gu J; Zhou D; Cheng W; Wu H; Wang Y; Tang T; Wang X
Cell Oncol (Dordr); 2021 Feb; 44(1):45-59. PubMed ID: 33423167
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
[TBL] [Abstract][Full Text] [Related]
10. MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.
Zhu M; Wang X; Gu Y; Wang F; Li L; Qiu X
Arch Biochem Biophys; 2019 Jan; 661():22-30. PubMed ID: 30389444
[TBL] [Abstract][Full Text] [Related]
11. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-452: a double-edged sword in multiple human cancers.
Karimi Dermani F; Datta I; Gholamzadeh Khoei S
Clin Transl Oncol; 2023 May; 25(5):1189-1206. PubMed ID: 36622551
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circ-PLCD1 functions as a tumor suppressor in non-small cell lung cancer by inactivation of PI3K/AKT signaling pathway.
Si J; Jin J; Sai J; Liu X; Luo X; Fu Z; Wang J
Hum Cell; 2022 May; 35(3):924-935. PubMed ID: 35301686
[TBL] [Abstract][Full Text] [Related]
14. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway.
Kannan M; Jayamohan S; Moorthy RK; Chabattula SC; Ganeshan M; Arockiam AJV
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698701
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
[TBL] [Abstract][Full Text] [Related]
16. The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor.
Ahmed EA; Rajendran P; Scherthan H
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682549
[TBL] [Abstract][Full Text] [Related]
17. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
18. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
[TBL] [Abstract][Full Text] [Related]
19. Double-edged sword role of miRNA-633 and miRNA-181 in human cancers.
Gupta J; Suliman M; Ali R; Margiana R; Hjazi A; Alsaab HO; Qasim MT; Hussien BM; Ahmed M
Pathol Res Pract; 2023 Aug; 248():154701. PubMed ID: 37542859
[TBL] [Abstract][Full Text] [Related]
20. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.
Du A; Li S; Zhou Y; Disoma C; Liao Y; Zhang Y; Chen Z; Yang Q; Liu P; Liu S; Dong Z; Razzaq A; Tao S; Chen X; Liu Y; Xu L; Zhang Q; Li S; Peng J; Xia Z
Mol Cancer; 2022 May; 21(1):109. PubMed ID: 35524319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
